Elsayed Balbaa: Baseline Anemia Predicts Adverse 12-Month Outcomes After Elective PCI for Stable CAD
Elsayed Balbaa, Student of Alexandria University, shared a post on LinkedIn:
“A new Publication!
We found that in men undergoing first-time elective PCI for stable CAD, baseline anemia was associated with higher 12-month risks of AKI, major bleeding, need for transfusion, hospitalization, and death, especially with recent (≤ 1 year) bleeding or transfusion history.”
Mohamed R. Murad, Bachelor of Medicine, Bachelor of Surgery – MBBS at Al-Azhar University, shared a post on LinkedIn:
“Pleased to share our recent publication:
‘Prognostic Impact of Baseline Anemia on Outcomes After Elective PCI in Men: A US Retrospective Cohort Study.’
In this study, we examined the prognostic impact of baseline anemia on outcomes after elective PCI in men with stable coronary artery disease.
Our analysis incorporated survival analysis, Kaplan-Meier curves, log-rank testing, univariable and multivariable Cox proportional hazards regression, propensity score matching, falsification (negative-control) endpoint analysis, E-value sensitivity analysis, and multiple-testing adjustment using Benjamini-Hochberg and Bonferroni methods.
I’m truly happy to be part of this great work with such outstanding leaders, collaborators, and team members.
I’m deeply grateful for the guidance, dedication, and shared effort of all co-authors who contributed to this study.
Proud to contribute to research that advances clinical understanding and supports better patient care.”
Title: Catheterization and Cardiovascular Interventions
Authors: Abdalhakim Shubietah, Mohamed S. Elgendy, Mohamed Saad Rakab, Ahmed Ahmed, Batoul Abusalah, Mohamed R. Murad, Belal Mohamed Hamed, Hamza A. Abdul-Hafez, Ahmed Emara, Qutaiba Qafisheh, Elsayed Balbaa, Ameer Awashra, Ahmed Mansour, Ahmed Elbataa, Abdalrahman Assaassa, Mohammed Mhanna
Read the Article on Catheterization and Cardiovascular Interventions
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 5, 2026, 19:00Kausik Ray: Comparing Lipid Management in France vs. Rest of Europe for High Cardiovascular Risk Patients
-
Apr 5, 2026, 18:22Omar Adwan: Systematic Approach to Blood Smear Examination
-
Apr 5, 2026, 18:05Heghine Khachatryan: Rethinking Hemostatic Targets in Pregnancy for von Willebrand Disease
-
Apr 5, 2026, 17:45Matthew Walls: Recognising CAD PRS as a New ‘Risk Enhancing Factor’ in the 2026 ACC/AHA Guidelines
-
Apr 5, 2026, 17:44Philip A. Chan: Occasional Heavy Drinking Leads to 3 Times Higher Liver Fibrosis Risk in MASLD
-
Apr 5, 2026, 17:42Josu de la Fuente: Real World Data Shows Significant Risk of Subsequent HCT in SCD and Thalassemia
-
Apr 5, 2026, 17:41Gevorg Yaghjyan: Attending an AI Conference on AI in Clinical Medicine, Research and Education
-
Apr 5, 2026, 17:41Ifeanyichukwu Ifechidere: The Mastermind of Clotting – A Thrombin Story
-
Apr 5, 2026, 17:38Thomas Ichim: Making iPSC Cells from Menstrual Blood Stem Cells